STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment
STAT News · LC · trust 53/100
ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on to something.
Read the original at STAT News →
Open in TruthVane →